Clinical Trial Update: Evaluation of the Efficacy and Safety of PRX-100 in the Treatment of Early to Moderate Presbyopia [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating PRX-100 for presbyopia has completed, assessing its efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Presbyopia

Drugs mentioned

• PRX-100 (PRX-100)

Snippet

Sponsor: LENZ Therapeutics, Inc | Conditions: Presbyopia | Phase 2 | Status: COMPLETED